These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7185522)
1. Treatment of spasticity with chlorpromazine in the behaviorally disturbed patient. Mayo MR; Ereshefsky L Clin Pharm; 1982; 1(3):257-62. PubMed ID: 7185522 [No Abstract] [Full Text] [Related]
2. [Lyseen in the treatment of cildren with mental disorders complicated by spastic paralysis]. Kwiatkowska E; Rosa-Garlicka Z Przegl Lek; 1969 Apr; 25(4):375-6. PubMed ID: 5790606 [No Abstract] [Full Text] [Related]
3. Phenytoin and chlorpromazine in the treatment of spasticity. Cohan SL; Raines A; Panagakos J; Armitage P Arch Neurol; 1980 Jun; 37(6):360-4. PubMed ID: 6248002 [TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and treatment of spasticity. Gulati SK J Assoc Physicians India; 1993 Apr; 41(4):225-6. PubMed ID: 8270566 [No Abstract] [Full Text] [Related]
6. Spasticity: a review. Young RR Neurology; 1994 Nov; 44(11 Suppl 9):S12-20. PubMed ID: 7970006 [TBL] [Abstract][Full Text] [Related]
7. Postoperative spasticity and shivering. Hopkin DA Anaesthesia; 1984 Jul; 39(7):725-6. PubMed ID: 6465504 [No Abstract] [Full Text] [Related]
8. [Chlorpromazine & atypical tuberculosis in 578 chronic mental patients; need for combined therapy]. HYVERT M; LE CLOAREC J; CARRER J Ann Med Psychol (Paris); 1957 Jul; 115(2):296-300. PubMed ID: 13458952 [No Abstract] [Full Text] [Related]
9. [Spasticity: today and tomorrow]. Bussel B Neurochirurgie; 2003 May; 49(2-3 Pt 2):413-6. PubMed ID: 12746720 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of facial muscle spasticity with intramuscular phenol neurolysis. Greenbaum MG; Young MA; Frank JM Arch Phys Med Rehabil; 1993 Feb; 74(2):217-9. PubMed ID: 8431109 [TBL] [Abstract][Full Text] [Related]
12. Comparative profile of tizanidine in the management of spasticity. Lataste X; Emre M; Davis C; Groves L Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011 [TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report. Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901 [TBL] [Abstract][Full Text] [Related]
14. [Measuring outcome in spasticity rehabilitation]. Fheodoroff K; Wissel J; Entner T; Freimüller M Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046 [TBL] [Abstract][Full Text] [Related]
15. The use of drugs in the treatment of spasticity. Lenman JA Proc R Soc Med; 1970 Sep; 63(9):935-7. PubMed ID: 5477076 [No Abstract] [Full Text] [Related]
16. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Simpson DM; Gracies JM; Graham HK; Miyasaki JM; Naumann M; Russman B; Simpson LL; So Y; Neurology; 2008 May; 70(19):1691-8. PubMed ID: 18458229 [TBL] [Abstract][Full Text] [Related]